Clinical Trial Update: CORE: Study to Evaluate the Conducted AF-Response-Algorithm in Patients Suffering From Heart Failure and Atrial Fibrillation [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports that Medtronic's CORE study evaluating the AF-Response-Algorithm in patients with heart failure and atrial fibrillati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Failure
• Sudden Cardiac Death

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Heart Failure, Sudden Cardiac Death | Phase 4 | Status: TERMINATED